MEIP - MEI Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,62223,249--
Cost of Revenue3,3835,000--
Gross Profit-1,76118,249--
Operating Expenses
Research Development17,0387,23713,40323,823
Selling General and Administrative9,7878,6287,6018,948
Non Recurring----
Total Operating Expenses30,20820,86521,00432,771
Operating Income or Loss-28,5862,384-21,004-32,771
Income from Continuing Operations
Total Other Income/Expenses Net-11,48128714378
Earnings Before Interest and Taxes-28,5862,384-21,004-32,771
Interest Expense----
Income Before Tax-40,0672,671-20,861-32,693
Income Tax Expense1111
Minority Interest----
Net Income From Continuing Ops-40,0682,670-20,862-32,694
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-40,0682,670-20,862-32,694
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-40,0682,670-20,862-32,694